Artemisinin-Derived Dimer Shows Strong Anti-CMV and Anti-Cancer Effects
Author Information
Author(s): He Ran, Bryan T. Mott, Andrew S. Rosenthal, Douglas T. Genna, Gary H. Posner, Ravit Arav-Boger
Primary Institution: Johns Hopkins University
Hypothesis
Artemisinin-derived dimers are more effective than monomers in inhibiting cytomegalovirus (CMV) replication and cancer cell growth.
Conclusion
The study found that the artemisinin-derived diphenyl phosphate dimer 838 is the most potent inhibitor of CMV replication and also effectively inhibits cancer cell growth.
Supporting Evidence
- Dimer 838 was found to be 165-fold more potent than artesunate in anti-CMV activity.
- Dimer 832-4 and 838 showed high selectivity indices, indicating low toxicity.
- Both dimers effectively inhibited a Ganciclovir-resistant CMV strain.
Takeaway
Scientists discovered that a new type of medicine made from artemisinin can stop a virus and help fight cancer better than older versions.
Methodology
The study involved testing various artemisinin-derived dimers and monomers for their ability to inhibit CMV replication and cancer cell growth in vitro.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo effectiveness.
Statistical Information
P-Value
p=0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website